Ameriprise’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-230,172
| Closed | -$5.39M | – | 3921 |
|
|
2024
Q2 | $5.39M | Buy |
230,172
+1,267
| +0.6% | +$29.7K | ﹤0.01% | 2246 |
|
|
2024
Q1 | $7.56M | Sell |
228,905
-37,090
| -14% | -$1.23M | ﹤0.01% | 2037 |
|
|
2023
Q4 | $7.24M | Buy |
265,995
+249,865
| +1,549% | +$6.8M | ﹤0.01% | 2060 |
|
|
2023
Q3 | $388K | Buy |
16,130
+6,657
| +70% | +$160K | ﹤0.01% | 3498 |
|
|
2023
Q2 | $302K | Buy |
+9,473
| New | +$302K | ﹤0.01% | 3602 |
|
|
2023
Q1 | – | Sell |
-7,337
| Closed | -$287K | – | 3936 |
|
|
2022
Q4 | $287K | Sell |
7,337
-49,291
| -87% | -$1.93M | ﹤0.01% | 3598 |
|
|
2022
Q3 | $2.7M | Buy |
+56,628
| New | +$2.7M | ﹤0.01% | 2638 |
|
|
2022
Q2 | – | Sell |
-9,732
| Closed | -$558K | – | 3895 |
|
|
2022
Q1 | $558K | Buy |
9,732
+7,217
| +287% | +$414K | ﹤0.01% | 3443 |
|
|
2021
Q4 | $200K | Buy |
+2,515
| New | +$200K | ﹤0.01% | 3784 |
|